Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Indivior Pharmaceuticals, Inc. - Common Stock
(NQ:
INDV
)
36.11
-1.26 (-3.37%)
Streaming Delayed Price
Updated: 2:58 PM EDT, Aug 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Indivior Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Earnings Scheduled For April 24, 2025
↗
April 24, 2025
Via
Benzinga
A Look at Indivior's Upcoming Earnings Report
↗
April 23, 2025
Via
Benzinga
Indivior PLC: Is This Deeply Undervalued Stock A Hidden Gem?
↗
April 13, 2025
With a strong position in a niche yet vital therapeutic area, Indivior PLC benefits from durable brand equity, a specialized distribution network, and a long runway for product innovation.
Via
Talk Markets
Topics
Stocks / Equities
European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat
↗
February 20, 2025
Indivior's 2025 outlook missed estimates, citing Suboxone sales erosion. The company plans $100 million in cost cuts, with $50M reinvested in Sublocade.
Via
Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
↗
February 20, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
Earnings Scheduled For February 20, 2025
↗
February 20, 2025
Via
Benzinga
Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
October 11, 2024
Via
Benzinga
S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results
↗
October 10, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 10, 2024
Via
Benzinga
Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings
↗
October 10, 2024
Via
Benzinga
Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details
↗
October 10, 2024
Indivior cuts FY24 net revenue outlook due to competition and funding delays, causing a drop in share price.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 10, 2024
Via
Benzinga
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm
October 01, 2024
From
The Schall Law Firm
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Indivior PLC (INDV)
September 30, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INDV Deadline: Rosen Law Firm Urges Indivior PLC (INDV) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
September 29, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 25, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Indivior PLC Investors to Secure Counsel Before Important October 1 Deadline in Securities Class Action – INDV
September 23, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Top 3 Health Care Stocks That May Explode This Month
↗
September 23, 2024
Via
Benzinga
INDIVIOR PLC (NASDAQ: INDV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline
September 23, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 21, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Indivior PLC REMINDER – INDV Stockholders Should Contact Robbins LLP for Information About the Indivior PLC Class Action and Pending Lead Plaintiff Deadline
September 18, 2024
From
Robbins LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 17, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 13, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
INVESTOR ALERT: DiCello Levitt LLP Shareholder Class Action Lawsuit Filed Against Indivior PLC (NASDAQ: INDV); Investors with Losses Encouraged to Discuss Their Options with Counsel
September 13, 2024
From
DiCello Levitt LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 09, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
INDIVIOR PLC (NASDAQ: INDV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline
September 09, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Smith & Wesson Brands Reports Downbeat Results, Joins Planet Labs PBC, Broadcom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
September 06, 2024
Via
Benzinga
French Biotech Candidate For Cannabis Use Disorder Fails Phase 2B Clinical Trial, Indivior Will Not Exercise Option
↗
September 04, 2024
Via
Benzinga
Topics
Cannabis
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
September 03, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
INDIVIOR PLC (NASDAQ: INDV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline
September 03, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
